Open access
Oct 2026
Liver-specific amino acid metabolism impacts on efficacy of cancer immunotherapy.
The combination immunotherapies, including those with atezolizumab and bevacizumab (Atez/Bev), have become standard therapy for hepatocellular carcinoma (HCC). However, its efficacy remains limited and reliable biomarkers are lacking. In this study, we analyzed paired tumor and background liver tissues from Atez/Bev-tr...
Yuma Fukumoto, Fumiaki Mukohara, Momoko Iwatsuru et al.
· Oncogene · 0 citations